Global Influenza Virus Vector Vaccine Market Growth (Status and Outlook) 2023-2029

March 2023 | 81 pages | ID: GA55EDD342A9EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The virus-sensitive vector vaccine, which is characterized by nasal drip vaccination, is currently undergoing safety and efficacy studies in experimental animals.

According to this study, the global Influenza Virus Vector Vaccine market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Virus Vector Vaccine market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Being Developed
• Preclinical
• Clinical I
• Clinical II

Segmentation by Application:

• Pharmaceutical And Biotechnology Companies
• Hospital
• Academic And Research Organizations
• Other

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• GREFFEX
• CanSino Biologics
• Academy of Military Medical Sciences
• XMU
• HKU
• Hualan Biological Engineering
• BravoBio

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Influenza Virus Vector Vaccine Market Size 2024-2029
  2.1.2 Influenza Virus Vector Vaccine Market Size CAGR by Region
2.2 Influenza Virus Vector Vaccine Segment by Type
  2.2.1 Being Developed
  2.2.2 Preclinical
  2.2.3 Clinical I
  2.2.4 Clinical II
2.3 Influenza Virus Vector Vaccine Market Size by Type
  2.3.1 Global Influenza Virus Vector Vaccine Market Size Market Share by Type (2024-2029)
  2.3.2 Global Influenza Virus Vector Vaccine Market Size Growth Rate by Type (2024-2029)
2.4 Influenza Virus Vector Vaccine Segment by Application
  2.4.1 Pharmaceutical And Biotechnology Companies
  2.4.2 Hospital
  2.4.3 Academic And Research Organizations
  2.4.4 Other
2.5 Influenza Virus Vector Vaccine Market Size by Application
  2.5.1 Global Influenza Virus Vector Vaccine Market Size Market Share by Application (2024-2029)
  2.5.2 Global Influenza Virus Vector Vaccine Market Size Growth Rate by Application (2024-2029)

3 INFLUENZA VIRUS VECTOR VACCINE KEY PLAYERS

3.1 Date of Key Players Enter into Influenza Virus Vector Vaccine
3.2 Key Players Influenza Virus Vector Vaccine Product Offered
3.3 Key Players Influenza Virus Vector Vaccine Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Influenza Virus Vector Vaccine Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 INFLUENZA VIRUS VECTOR VACCINE BY REGIONS

4.1 Influenza Virus Vector Vaccine Market Size by Regions (2024-2029)
4.2 United States Influenza Virus Vector Vaccine Market Size Growth (2024-2029)
4.3 China Influenza Virus Vector Vaccine Market Size Growth (2024-2029)
4.4 Europe Influenza Virus Vector Vaccine Market Size Growth (2024-2029)
4.5 Rest of World Influenza Virus Vector Vaccine Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States Influenza Virus Vector Vaccine Market Size by Type (2024-2029)
5.2 United States Influenza Virus Vector Vaccine Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe Influenza Virus Vector Vaccine Market Size by Type (2024-2029)
6.2 Europe Influenza Virus Vector Vaccine Market Size by Application (2024-2029)

7 CHINA

7.1 China Influenza Virus Vector Vaccine Market Size by Type (2024-2029)
7.2 China Influenza Virus Vector Vaccine Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World Influenza Virus Vector Vaccine Market Size by Type (2024-2029)
8.2 Rest of World Influenza Virus Vector Vaccine Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN INFLUENZA VIRUS VECTOR VACCINE

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 GREFFEX
  11.1.1 GREFFEX Company Details
  11.1.2 GREFFEX Influenza Virus Vector Vaccine Product Offered
  11.1.3 GREFFEX Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
  11.1.4 GREFFEX Main Business Overview
  11.1.5 GREFFEX News
11.2 CanSino Biologics
  11.2.1 CanSino Biologics Company Details
  11.2.2 CanSino Biologics Influenza Virus Vector Vaccine Product Offered
  11.2.3 CanSino Biologics Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
  11.2.4 CanSino Biologics Main Business Overview
  11.2.5 CanSino Biologics News
11.3 Academy of Military Medical Sciences
  11.3.1 Academy of Military Medical Sciences Company Details
  11.3.2 Academy of Military Medical Sciences Influenza Virus Vector Vaccine Product Offered
  11.3.3 Academy of Military Medical Sciences Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
  11.3.4 Academy of Military Medical Sciences Main Business Overview
  11.3.5 Academy of Military Medical Sciences News
11.4 XMU
  11.4.1 XMU Company Details
  11.4.2 XMU Influenza Virus Vector Vaccine Product Offered
  11.4.3 XMU Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
  11.4.4 XMU Main Business Overview
  11.4.5 XMU News
11.5 HKU
  11.5.1 HKU Company Details
  11.5.2 HKU Influenza Virus Vector Vaccine Product Offered
  11.5.3 HKU Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
  11.5.4 HKU Main Business Overview
  11.5.5 HKU News
11.6 Hualan Biological Engineering
  11.6.1 Hualan Biological Engineering Company Details
  11.6.2 Hualan Biological Engineering Influenza Virus Vector Vaccine Product Offered
  11.6.3 Hualan Biological Engineering Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
  11.6.4 Hualan Biological Engineering Main Business Overview
  11.6.5 Hualan Biological Engineering News
11.7 BravoBio
  11.7.1 BravoBio Company Details
  11.7.2 BravoBio Influenza Virus Vector Vaccine Product Offered
  11.7.3 BravoBio Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
  11.7.4 BravoBio Main Business Overview
  11.7.5 BravoBio News
...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Influenza Virus Vector Vaccine Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Being Developed
Table 3. Major Players of Preclinical
Table 4. Major Players of Clinical I
Table 5. Major Players of Clinical II
Table 6. Global Influenza Virus Vector Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 7. Global Influenza Virus Vector Vaccine Market Size Market Share by Type (2024-2029)
Table 8. Global Influenza Virus Vector Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 9. Global Influenza Virus Vector Vaccine Market Size Market Share by Application (2024-2029)
Table 10. Date of Global Key Players Enter into Influenza Virus Vector Vaccine Market
Table 11. Global Key Players Influenza Virus Vector Vaccine Product Offered
Table 12. Key Players Influenza Virus Vector Vaccine Funding/Investment ($ Millions)
Table 13. Funding/Investment by Regions
Table 14. Funding/Investment by End Industry
Table 15. Key Players Influenza Virus Vector Vaccine Valuation & Market Capitalization ($ Millions)
Table 16. Key Players Mergers & Acquisitions, Expansion Plans
Table 17. Influenza Virus Vector Vaccine New Product/Technology Launches
Table 18. Influenza Virus Vector Vaccine Industry Partnerships, Agreements, and Collaborations
Table 19. Influenza Virus Vector Vaccine Industry Mergers and Acquisitions
Table 20. Global Influenza Virus Vector Vaccine Market Size by Regions 2024-2029 ($ Millions)
Table 21. Global Influenza Virus Vector Vaccine Market Size Market Share by Regions 2024-2029
Table 22. United States Influenza Virus Vector Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 23. United States Influenza Virus Vector Vaccine Market Size Market Share by Type (2024-2029)
Table 24. United States Influenza Virus Vector Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 25. United States Influenza Virus Vector Vaccine Market Size Market Share by Application (2024-2029)
Table 26. Europe Influenza Virus Vector Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 27. Europe Influenza Virus Vector Vaccine Market Size Market Share by Type (2024-2029)
Table 28. Europe Influenza Virus Vector Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 29. Europe Influenza Virus Vector Vaccine Market Size Market Share by Application (2024-2029)
Table 30. China Influenza Virus Vector Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 31. China Influenza Virus Vector Vaccine Market Size Market Share by Type (2024-2029)
Table 32. China Influenza Virus Vector Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 33. China Influenza Virus Vector Vaccine Market Size Market Share by Application (2024-2029)
Table 34. Rest of World Influenza Virus Vector Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 35. Rest of World Influenza Virus Vector Vaccine Market Size Market Share by Type (2024-2029)
Table 36. Rest of World Influenza Virus Vector Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 37. Rest of World Influenza Virus Vector Vaccine Market Size Market Share by Application (2024-2029)
Table 38. Key Market Drivers & Growth Opportunities of Influenza Virus Vector Vaccine
Table 39. Key Market Challenges & Risks of Influenza Virus Vector Vaccine
Table 40. Key Industry Trends of Influenza Virus Vector Vaccine
Table 41. Company A Company Details
Table 42. Companies Invested by Company A
Table 43. Company A Key Development and Market Layout
Table 44. Company B Company Details
Table 45. Companies Invested by Company B
Table 46. Company B Key Development and Market Layout
Table 47. Company C Company Details
Table 48. Companies Invested by Company C
Table 49. Company C Key Development and Market Layout
Table 50. Company C Company Details
Table 51. Companies Invested by Company C
Table 52. Company C Key Development and Market Layout
Table 53. GREFFEX Basic Information, Head Office, Major Market Areas and Its Competitors
Table 54. GREFFEX Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
Table 55. CanSino Biologics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. CanSino Biologics Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
Table 57. Academy of Military Medical Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Academy of Military Medical Sciences Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
Table 59. XMU Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. XMU Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
Table 61. HKU Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. HKU Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
Table 63. Hualan Biological Engineering Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. Hualan Biological Engineering Influenza Virus Vector Vaccine Market Size (2023 VS 2029)
Table 65. BravoBio Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. BravoBio Influenza Virus Vector Vaccine Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Influenza Virus Vector Vaccine
Figure 2. Influenza Virus Vector Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Virus Vector Vaccine Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. Influenza Virus Vector Vaccine Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global Influenza Virus Vector Vaccine Market Size Market Share by Type (2024-2029)
Figure 9. Global Being Developed Market Size Growth Rate
Figure 10. Global Preclinical Market Size Growth Rate
Figure 11. Global Clinical I Market Size Growth Rate
Figure 12. Global Clinical II Market Size Growth Rate
Figure 13. Influenza Virus Vector Vaccine in Pharmaceutical And Biotechnology Companies
Figure 14. Global Influenza Virus Vector Vaccine Market: Pharmaceutical And Biotechnology Companies (2024-2029) ($ Millions)
Figure 15. Influenza Virus Vector Vaccine in Hospital
Figure 16. Global Influenza Virus Vector Vaccine Market: Hospital (2024-2029) ($ Millions)
Figure 17. Influenza Virus Vector Vaccine in Academic And Research Organizations
Figure 18. Global Influenza Virus Vector Vaccine Market: Academic And Research Organizations (2024-2029) ($ Millions)
Figure 19. Influenza Virus Vector Vaccine in Other
Figure 20. Global Influenza Virus Vector Vaccine Market: Other (2024-2029) ($ Millions)
Figure 21. Global Influenza Virus Vector Vaccine Market Size Market Share by Application (2024-2029)
Figure 22. Global Influenza Virus Vector Vaccine Market Size in Pharmaceutical And Biotechnology Companies Growth Rate
Figure 23. Global Influenza Virus Vector Vaccine Market Size in Hospital Growth Rate
Figure 24. Global Influenza Virus Vector Vaccine Market Size in Academic And Research Organizations Growth Rate
Figure 25. Global Influenza Virus Vector Vaccine Market Size in Other Growth Rate
Figure 26. Funding/Investment
Figure 27. Global Influenza Virus Vector Vaccine Market Size Market Share by Regions 2024-2029
Figure 28. United States Influenza Virus Vector Vaccine Market Size 2024-2029 ($ Millions)
Figure 29. China Influenza Virus Vector Vaccine Market Size 2024-2029 ($ Millions)
Figure 30. Europe Influenza Virus Vector Vaccine Market Size 2024-2029 ($ Millions)
Figure 31. Rest of World Influenza Virus Vector Vaccine Market Size 2024-2029 ($ Millions)
Figure 32. United States Influenza Virus Vector Vaccine Consumption Market Share by Type in 2029
Figure 33. United States Influenza Virus Vector Vaccine Market Size Market Share by Application in 2029
Figure 34. China Influenza Virus Vector Vaccine Consumption Market Share by Type in 2029
Figure 35. China Influenza Virus Vector Vaccine Market Size Market Share by Application in 2029
Figure 36. Europe Influenza Virus Vector Vaccine Consumption Market Share by Type in 2029
Figure 37. Europe Influenza Virus Vector Vaccine Market Size Market Share by Application in 2029
Figure 38. Rest of World Influenza Virus Vector Vaccine Consumption Market Share by Type in 2029
Figure 39. Rest of World Influenza Virus Vector Vaccine Market Size Market Share by Application in 2029